Health and Fitness Health and Fitness
Mon, March 4, 2013
Sun, March 3, 2013
Sat, March 2, 2013
Fri, March 1, 2013
Thu, February 28, 2013
Wed, February 27, 2013
Tue, February 26, 2013
Mon, February 25, 2013
Sun, February 24, 2013
Sat, February 23, 2013
Fri, February 22, 2013
Thu, February 21, 2013
[ Thu, Feb 21st 2013 ] - Market Wire
Inorganic Growth of Healthcare
Wed, February 20, 2013
Tue, February 19, 2013
Mon, February 18, 2013
Sun, February 17, 2013
Fri, February 15, 2013
Thu, February 14, 2013
Wed, February 13, 2013
Tue, February 12, 2013
Mon, February 11, 2013
Sun, February 10, 2013
Fri, February 8, 2013

Transcept Pharmaceuticals to Report Fourth Quarter and Full Year 2012 Financial Results and Host Conference Call on February 27


//health-fitness.news-articles.net/content/2013/ .. lts-and-host-conference-call-on-february-27.html
Published in Health and Fitness on Thursday, February 21st 2013 at 4:01 GMT by Market Wire   Print publication without navigation


Transcept Pharmaceuticals to Report Fourth Quarter and Full Year 2012 Financial... -- POINT RICHMOND, Calif., Feb. 21, 2013 /PRNewswire/ --

POINT RICHMOND, Calif., Feb. 21, 2013 /PRNewswire/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: [ TSPT ]), a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience, today announced that the company will host a conference call on Wednesday, February 27, 2013, at 4:30 p.m. Eastern Time to discuss its fourth quarter and full year 2012 financial results. The conference call will follow the release of the Transcept fourth quarter and full year 2012 financial results after the close of market that day.

Conference Call Information


Date: Wednesday, February 27, 2013


Time: 4:30 p.m. ET


Dial-in (U.S.): 877-638-4558


Dial-in (International): 914-495-8537

A simultaneous webcast of the conference call will be available on the Investors section of the Transcept website at [ www.transcept.com ]. A replay of this webcast will be available on the website shortly after the conclusion of the call through March 31, 2013.

About Transcept
Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience. Intermezzo® (zolpidem tartrate) sublingual tablet C-IV is the first FDA approved Transcept product. Purdue Pharma holds commercialization and development rights for Intermezzo in the United States. For further information about Transcept, please visit [ www.transcept.com ]. For information about Intermezzo, please visit [ www.MyIntermezzo.com ].

Contact:
Transcept Pharmaceuticals, Inc.
Greg Mann
Sr. Director, Corporate Communications
(510) 215-3567
[ gmann@transcept.com ]

SOURCE Transcept Pharmaceuticals, Inc.



RELATED LINKS
[ http://www.transcept.com ]
[ http://www.myintermezzo.com ]

Publication Contributing Sources